BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14682344)

  • 1. Vaccine hope for acute promyelocytic leukaemia.
    Ahmad K
    Lancet Oncol; 2003 Dec; 4(12):712. PubMed ID: 14682344
    [No Abstract]   [Full Text] [Related]  

  • 2. Tracking the extramedullary PML-RARα-positive cell reservoirs in a preclinical model: biomarker of long-term drug efficacy.
    Pokorna K; Le Pogam C; Chopin M; Balitrand N; Reboul M; Cassinat B; Chomienne C; Padua RA; Pla M
    Mol Cell Probes; 2013 Feb; 27(1):1-5. PubMed ID: 22906630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA vaccine against acute promyelocytic leukemia in the mouse.
    Rosti V
    Haematologica; 2005 Aug; 90(8):1010B. PubMed ID: 16079090
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
    Gutiérrez de Guzmán J; Kantarjian H
    Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
    [No Abstract]   [Full Text] [Related]  

  • 5. Murine acute promyelocytic leukemia cells can be recognized and cleared in vivo by adaptive immune mechanisms.
    Pollock JL; Lane AA; Schrimpf K; Ley TJ
    Haematologica; 2005 Aug; 90(8):1042-9. PubMed ID: 16079103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.
    Padua RA; Larghero J; Robin M; le Pogam C; Schlageter MH; Muszlak S; Fric J; West R; Rousselot P; Phan TH; Mudde L; Teisserenc H; Carpentier AF; Kogan S; Degos L; Pla M; Bishop JM; Stevenson F; Charron D; Chomienne C
    Nat Med; 2003 Nov; 9(11):1413-7. PubMed ID: 14566333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continued complete remission after a PML/RAR-alpha+ autograft in acute promyelocytic leukaemia.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Ruiz-Argüelles A
    Eur J Haematol; 1996 Mar; 56(3):186-7. PubMed ID: 8598242
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF; Solomon E
    Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.
    Mikoshiba M; Ohashi K; Takei N; Okuyama Y; Maeda Y; Hiruma K; Akiyama H; Fukuhara O; Takeshita A; Sakamaki H
    Int J Hematol; 2002 Jan; 75(1):104-6. PubMed ID: 11843281
    [No Abstract]   [Full Text] [Related]  

  • 10. Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia.
    Quignon F; Chen Z; de Thé H
    Biochim Biophys Acta; 1997 Dec; 1333(3):M53-61. PubMed ID: 9426202
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
    Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer.
    Mai TJ; Ma R; Li Z; Bi SC
    Braz J Med Biol Res; 2016 Oct; 49(11):e5620. PubMed ID: 27783810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The short form of PML-RARalpha fusion transcript is associated with poor survival.
    Albitar M; Chang KS; Pierce S; Kantarjian H; Estey E
    Leuk Res; 1999 Jan; 23(1):89-92. PubMed ID: 9933141
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.
    Ottaviani E; Martinelli G; Testoni N; Visani G; Tani M; Tura S
    Haematologica; 1998 Nov; 83(11):1051-5. PubMed ID: 9864933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of acute promyelocytic leukemia in the external auditory canal confirmed by PML/RARA dual-fusion and RARA break-apart fluorescence in situ hybridization.
    Minoda S; Akasaka T; Okanoue Y; Honjo G; Nakagawa M; Ohno H
    Ann Hematol; 2018 May; 97(5):909-911. PubMed ID: 29387977
    [No Abstract]   [Full Text] [Related]  

  • 16. How should we prevent hematologic relapse of acute promyelocytic leukemia?
    Nagai S; Takahashi T; Kurokawa M
    J Clin Oncol; 2010 Feb; 28(4):e62; author reply e63-4. PubMed ID: 19841316
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute promyelocytic leukemia: a view from a mouse.
    Kogan SC
    Blood Cells Mol Dis; 2000 Dec; 26(6):620-5. PubMed ID: 11358354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation.
    Tedeschi A; Cairoli R; Marenco P; Nosari A; Tresoldi E; Di Bona E; Montillo M; Morra E
    Leukemia; 2002 Dec; 16(12):2455-6. PubMed ID: 12454753
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidermal growth factor in acute promyelocytic leukemia treated with retinoic acid.
    Wu X; Qureshi IA; Liu H; Yin J; Qian X; Ruijie X
    Int J Hematol; 1995 Aug; 62(2):83-9. PubMed ID: 8590777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
    Lo Coco F; Diverio D; Avvisati G; Mandelli F
    Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.